DRL recalls 80,000+ bottles of Atorvastatin from US
The product was manufactured at the drug maker’s Srikakulam plant in Andhra Pradesh
Dr Reddy’s Laboratories (DRL) has initiated…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Aurobindo Pharma posts Q3 net profit at Rs 595 cr
Revenues from operations grew by 11 per cent to Rs 4,336 crore
Cipla Q3 profit up 7 per cent to Rs 4 bn
India revenue swells 15 per cent to Rs 16 bn
EMA to shift base from London to Amsterdam
Management board meets in an extraordinary session to discuss EMA’s future premises in Amsterdam
MoH&FW drafts Clinical Trial Rules, 2018
The government has invited suggestion/ comment/ objection within 45 days of gazatte notification
YLB’s phase III clinical trial of Etanercept biosimilar meets positive outcome
The study was a multinational randomised double-blind controlled trial of 52 weeks duration which included more than 500 patients…
Lupin Q3 net profit dips 65 pc to Rs 222 cr
Consolidated income from operations also declined to Rs 3,900.36 crore
Natco Pharma Q3 net profit up 12 pc at Rs 217.4 cr
Consolidated total revenues of the company stood at Rs 573.6 crore
SRMC inks pact with German varsity
Students can take up courses in medical information management, clinical research or epidemiology
Alcon wins ASSOCHAM Medical Technology Excellence Awards
The event honoured Alcon India for its contribution in medical technology in India
Independent Task Force launched to downstage oral cancer set up
The mission of the task force will be to ideate, educate and engage stakeholders, thereby effectively down-staging oral cancer in…
Prof Michael N Hall to receive 2018 Genome Valley Excellence Award
The award will be presented to him during the inauguration ceremony of BioAsia 2018
Antibiotics sold in India pose global superbug threat
India has among the highest rates globally of antimicrobial resistance and antibiotic consumption
LANXESS renews partnership with Novozymes
The two organisations will continue to cooperate on existing enzyme solutions and joint innovations for future enzyme technologies
Oraxion Therapeutics executes exclusive option to license ORX-301
Exclusive option agreement on ORX-301 for treating NPC and FSGS has the potential to reach over $125 million in payments
Assam to attract more pharma players with better investment policies
MoU signed between Indian Institute of Technology-Guwahati and Kalam Institute of Health Technology
GlaxoSmithKline Pharmaceuticals announces Q3 result
The company reports Profit Before Tax (PBT) at Rs 140 crores and Profit After Tax (PAT) at Rs 90 crores
Marksman to host INMAS in Mumbai
Theme of the event is Preparing Next Generation Medical Affairs Personnel
DRL launches Tetrabenazine tabs in the US
Tetrabenazine Tablets are available in strengths of 12.5 mg and 25 mg, each strength is available in a bottle count size of 112
Lupin launches generic Clobex lotion in US
The company has received an approval from US FDA